Participants 15 35 3
children with autism
Participants 322 342 3
children with autism
Participants 548 718 4
40 consecutive children with autism, whose ages ranged from 2 to 9 years, who were receiving either risperidone or placebo given orally at a dose of 1 mg/day for 6 months
Participants 922 942 3
40 children enrolled
